- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 47/54 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
Patent holdings for IPC class A61K 47/54
Total number of patents in this class: 5406
10-year publication summary
108
|
186
|
295
|
507
|
656
|
673
|
826
|
928
|
891
|
270
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Alnylam Pharmaceuticals, Inc. | 1066 |
80 |
The Regents of the University of California | 18943 |
71 |
Dana-Farber Cancer Institute, Inc. | 2455 |
66 |
Purdue Research Foundation | 3277 |
60 |
Massachusetts Institute of Technology | 9795 |
57 |
Sapreme Technologies B.V. | 74 |
51 |
Northwestern University | 3112 |
43 |
Yale University | 2204 |
42 |
Modernatx, Inc. | 1181 |
36 |
Arvinas Operations, Inc. | 165 |
34 |
City of Hope | 943 |
33 |
Ionis Pharmaceuticals, Inc. | 776 |
33 |
Arrowhead Pharmaceuticals, Inc. | 216 |
32 |
Centre National de La Recherche Scientifique | 9632 |
30 |
Novartis AG | 11238 |
28 |
University of Massachusetts | 2130 |
28 |
Merck Sharp & Dohme LLC | 3689 |
23 |
The Johns Hopkins University | 5377 |
22 |
Daiichi Sankyo Company, Limited | 1829 |
22 |
Nammi Therapeutics, Inc. | 31 |
22 |
Other owners | 4593 |